(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

We are (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS:477600-68-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
CAS.NO:477600-68-3
Synonyms:(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
cis-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride
(3S,4S)-rel-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 302.6±35.0 °C at 760 mmHg
Molecular Formula C14H22N2
Molecular Weight 218.338
Flash Point 107.4±16.9 °C
 
Specification:
Appearance:White powder
Assay(GC):≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Tofacitinib(CAS:477600-75-2).

(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride


Related News: A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).149806-06-4 The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.Ácido Glicirrícico Dipotasio Sal Hidrato CAS:68797-35-3 Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.diethyl maleate CAS:141-05-9 Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.

Related Products
Product Name
2-Amino-6-bromobenzoic acid View Details
1-Cyano-4-dimethylaminopyridinium tetrafluoroborate Cas:59016-56-7 View Details
Calcium stearate View Details
PZM21 Cas:1997387-43-5 manufacturer 2,2-dimethyl-6-nitro-4H-pyrido[3,2-b][1,4]oxazin-3-one manufacturer Triethylmethylammonium chloride manufacturer 3-(Trifluoromethyl)benzonitrile manufacturer (3-chloropropyl)methyldimethoxysilane manufacturer